PRESS RELEASE published on 09/02/2025 at 09:22, 6 months 21 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA issued a declaration regarding the number of shares and voting rights. Total shares: 97,330,405. Total voting rights: 165,544,375 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech SA
BRIEF published on 08/04/2025 at 10:55, 7 months 19 days ago Sartorius Stedim Biotech: Number of shares and voting rights Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 08/04/2025 at 10:50, 7 months 19 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA: Declaration of the number of shares and voting rights in the issued capital as of July 31, 2025 Voting Rights Déclaration Shares Sartorius Stedim Biotech Issued Capital
BRIEF published on 07/22/2025 at 07:07, 8 months 1 day ago Sartorius Stedim Biotech Releases H1 2025 Financial Report Business Development Biopharmaceutical Industry Half-year Results Sartorius Stedim 2025 Financial Report
BRIEF published on 07/22/2025 at 07:05, 8 months 1 day ago Sartorius Stedim Biotech Reports Solid Half-Year 2025 Results Profitability Sales Growth Sartorius Stedim Biotech Biopharmaceutical Industry Half-year Results 2025
PRESS RELEASE published on 07/22/2025 at 07:02, 8 months 1 day ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech SA releases first half 2025 results and full year forecast. Report available online with financial statements and company profile Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry First Half 2025 Results
PRESS RELEASE published on 07/22/2025 at 07:00, 8 months 1 day ago Half-year results 2025 of Sartorius Stedim Biotech Sartorius Stedim Biotech reports strong half-year results for 2025 with sales revenue up 9.4% in constant currencies and underlying EBITDA rising by 19.3% Sartorius Stedim Biotech Sales Revenue Half-year Results 2025 Underlying EBITDA
BRIEF published on 07/03/2025 at 10:04, 8 months 20 days ago Sartorius Stedim Biotech SA: Share and Voting Rights Declaration Voting Rights Shares Issued Capital Regulatory News Sartorius Stedim
BRIEF published on 07/03/2025 at 10:03, 8 months 20 days ago Sartorius Stedim Biotech Half-Year Liquidity Contract Update Liquidity Shares Market Practice Buy-Sell Trade Volume
PRESS RELEASE published on 07/03/2025 at 09:59, 8 months 20 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital per regulatory requirements Voting Rights Capital Shares Sartorius Stedim Biotech SA Regulatory Requirements
Published on 03/23/2026 at 13:05, 34 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 1 hour 7 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 1 hour 9 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 12:30, 1 hour 9 minutes ago High Tide Resources Announces Closing of Concurrent Non-Brokered Private Placements for Gross Proceeds of $8.3 Million
Published on 03/23/2026 at 12:20, 1 hour 19 minutes ago Guanajuato Silver Adds Veteran Mine Operator to Board of Directors
Published on 03/23/2026 at 12:40, 59 minutes ago EQS-Adhoc: Ströer plans a dividend of €1.85 for fiscal year 2025 and approves a share buyback program of up to €50 million
Published on 03/20/2026 at 19:00, 2 days 18 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 2 days 19 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 16:57, 2 days 20 hours ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 3 days 19 hours ago Filing of the 2025 Universal Registration Document
